The company utilizes its self-developed technology platform, with over 20 R&D pipelines covering mainstream targets of autoimmune diseases, and multiple projects in different stages of development. The products under development belong to the national first-class new drugs, and the therapeutic fields involved have a market worth billions of dollars.

　　The R&D center is an independent building with an area of over 1700 square meters, including functional zones such as clean cell rooms, molecular biology laboratories, protein purification laboratories, quality analysis laboratories, pharmacological efficacy laboratories, etc. It is equipped with instruments and equipment including flow cytometry, capillary electrophoresis, high-performance liquid chromatography, etc., to meet the needs of laboratory research.